Brian Cahill - Dec 19, 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Stock symbol
EGRX
Transactions as of
Dec 19, 2022
Transactions value $
-$13,844
Form type
4
Date filed
12/21/2022, 03:17 PM
Previous filing
Mar 2, 2022
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$13.8K -461 -1.41% $30.03 32.2K Dec 19, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the company to satisfy tax withholding obligations in connection with the settlement of restricted stock units.